Utilizing personalized tumor-specific methylation haplotypes of circulating tumor DNA for monitoring minimal residual disease in hepatocellular carcinoma patients after curative resection

被引：1
|
作者：
Yang, X. [1 ]
Guo, D. [1 ]
Zhang, S-Y. [1 ]
Xu, M-J. [2 ]
Chen, H. [2 ]
Ma, C. [2 ]
Su, M-Y. [2 ]
He, Q. [2 ]
Zhang, Y. [2 ]
Su, Z. [2 ]
Liu, R. [2 ]
Fan, J. [1 ]
Zhou, J. [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp Affiliated, Dept Liver Surg & Transplantat, Shanghai, Peoples R China
[2] Singlera Genom Inc, R&D, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
958P
引用
收藏
页码：S661 / S662
页数：2
相关论文
共 50 条
  • [11] Clinical validation of a novel circulating tumor DNA methylation assay for predicting recurrence of colorectal cancer in patients with curative-intent surgery by monitoring minimal residual disease.
    Kim, Jin-Soo
    Lee, Yun Young
    Kim, Young
    An, Joon
    Shin, Rumi
    Park, Jin Hyun
    Han, Jinil
    Choi, In Sil
    Heo, Seung Chul
    Moon, Youngho
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [12] Analytical and clinical validation of a personalized, tumor-informed circulating tumor DNA assay for minimal residual disease detection
    Yang, Zuoquan
    Zhou, Yanqing
    Chen, Yaru
    Teng, Jiaman
    An, Heng
    Cheng, Shaochen
    Xu, Mingyan
    Chen, Shifu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [13] Circulating tumor-specific DNA: A marker for monitoring efficacy of adjuvant therapy in cancer patients
    Fiegl, H
    Millinger, S
    Mueller-Holzner, E
    Marth, C
    Ensinger, C
    Berger, A
    Klocker, H
    Goebel, G
    Widschwendter, M
    CANCER RESEARCH, 2005, 65 (04) : 1141 - 1145
  • [14] Clinical experience of a personalized and tumor-informed circulating tumor DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients
    Cohen, S.
    Hook, N.
    Krinshpun, S.
    Westbrook, L.
    Loranger, K.
    Wallace, J.
    Aleshin, A.
    Billings, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S229 - S229
  • [15] Circulating Tumor DNA Minimal Residual Disease Assay Predicts Outcome in Lung Cancer Patients Who Had Curative Treatments
    Yoon, S. M.
    Park, J. H.
    Oh, Y.
    Kim, L.
    Chae, Y. K.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S580 - S581
  • [16] Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study
    Li, Yaqi
    Xu, Jing
    Hu, Xiang
    Chen, Yikuan
    Liu, Fangqi
    Chen, Yun
    Ma, Xiaoji
    Dong, Qiduo
    Sun, Lei
    Mo, Shaobo
    Zhang, Long
    He, Xingfeng
    Tong, Shanyou
    Wu, Huizi
    Li, Wenhua
    Cai, Sanjun
    Zhu, Shida
    Pan, Qi
    Peng, Junjie
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (05) : 2776 - 2787
  • [17] Circulating tumor DNA methylation marker-based minimal residual diseases detection and recurrence monitoring of cancer
    Wang, Huiyong
    Pan, Xiaobao
    Wang, Lin
    Li, Chao
    Ma, Chao
    Yu, Shuai
    Meng, Fanyang
    Liu, Jing
    Liu, Liang
    Cao, Zhanbo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [18] Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases
    Loupakis, Fotios
    Sharma, Shruti
    Derouazi, Madiha
    Murgioni, Sabina
    Biason, Paola
    Rizzato, Mario Domenico
    Rasola, Cosimo
    Renner, Derrick
    Shchegrova, Svetlana
    Malashevich, Allyson Koyen
    Malhotra, Meenakshi
    Sethi, Himanshu
    Zimmermann, Bernhard G.
    Aleshin, Alexey
    Moshkevich, Solomon
    Billings, Paul R.
    Sedgwick, Jonathon D.
    Schirripa, Marta
    Munari, Giada
    Cillo, Umberto
    Pilati, Pierluigi
    Dei Tos, Angelo Paolo
    Zagonel, Vittorina
    Lonardi, Sara
    Fassan, Matteo
    JCO PRECISION ONCOLOGY, 2021, 5 : 1166 - 1177
  • [19] Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)
    Abdelrahim, M.
    Esmail, A.
    He, A. R.
    Franses, J.
    Bhan, I.
    Victor, D. W.
    Kodali, S.
    Connor, A. A.
    Saharia, A.
    Brdiges, C.
    Tin, T.
    Brewer, C.
    Jurdi, A.
    Liu, M. C.
    Ghobrial, R. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S600 - S600
  • [20] Monitoring of Circulating Tumor DNA As Minimal Residual Disease in Diffuse Large B-Cell Lymphoma
    Roschewski, Mark
    Dunleavy, Kieron
    Pittaluga, Stefania
    Kong, Katie
    Shovlin, Margaret
    Jaffe, Elaine S.
    Staudt, Louis M.
    Lai, Catherine
    Chen, Clara C.
    Zheng, Jianbiao
    Willis, Thomas D.
    Faham, Malek
    Wilson, Wyndham H.
    BLOOD, 2014, 124 (21)
12345